Your browser doesn't support javascript.
loading
Novel Pharmacotherapies for Hyperlipidemia.
Reamy, Brian V; Ford, Brian; Goodman, Charles.
Afiliación
  • Reamy BV; Academic Affairs, Uniformed Services University School of Medicine, 4301 Jones Bridge Road, Bethesda, MD 20814, USA. Electronic address: brian.reamy@usuhs.edu.
  • Ford B; Uniformed Services University School of Medicine, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.
  • Goodman C; Uniformed Services University School of Medicine, 4301 Jones Bridge Road, Bethesda, MD 20814, USA.
Prim Care ; 51(1): 27-40, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38278571
ABSTRACT
The link between elevated LDL-C, low HDL-C, elevated triglycerides, and an increased risk for cardiovascular disease has solidified over the past decades. Concomitantly, the number of agents to treat dyslipidemia proliferated in clinical trials, proving or refuting their clinical efficacy. Many of these agents' role in reducing cardiovascular disease morbidity and mortality is now clear. Recently, there has been an explosion in emerging therapeutics for the primary and secondary prevention of cardiovascular disease through the control of dyslipidemia. This article reviews standard, new, and emerging treatments for hyperlipidemia.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Dislipidemias / Hiperlipidemias Límite: Humans Idioma: En Revista: Prim Care Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Dislipidemias / Hiperlipidemias Límite: Humans Idioma: En Revista: Prim Care Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos